Delivery Order SPE2DB22D1017-SPE2DB25FG7MC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count supply) with a ceiling value of $2,574.31 under a firm fixed price contract. The award was made on August 20, 2025, with ultimate completion targeted for August 21, 2025. This delivery order represents a non-set-aside, competitively awarded contract and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate...
- The Defense Logistics Agency awarded a $3,203.82 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count supply) on July 28, 2025, with an ultimate completion date of July 29, 2025. This is a firm fixed-price, non-set-aside contract with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a purchase of a generic antifungal medication for federal medical supply needs, likely supporting military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Terbinafine HCL 250 mg tablets (30-count units) valued at $1,325.82 with a firm fixed price structure. This award represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 16, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Terbinafine is an antifungal medication...
- The Defense Logistics Agency awarded a $30,437.82 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count packaging) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $1,436.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,108.47 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a $2,372.46 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $27,178.87 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This firm fixed-price, competitively awarded contract was executed on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Terbinafine HCL 250 mg tablets (100-count units) with a ceiling value of $5,698.05. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award under the company's broader pharmaceutical supply relationship with DLA. The contract requires completion by June 20, 2025, with performance taking place at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 with a ceiling value of $5,904.08. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure and is scheduled for completion by September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG7MCDelivery Order
The Defense Logistics Agency awarded a $2,911.42 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count) on July 16, 2025, with completion scheduled for July 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Terbinafine is a commonly used antifungal medication that supports military and federal healthcare system requirements across the Defense Health Agency and related federal agencies. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime vehicle enables AmerisourceBergen to supply pharmaceutical products and medical supplies globally to support military healthcare programs. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen serves as a critical federal vendor, fulfilling diverse medical procurement needs ranging from specialty medications to vaccines and medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/16/25 |